Auci D L, Chice S M, Heusser C, Athanassiades T J, Durkin H G
Department of Pathology, State University of New York Health Science Center, Brooklyn 11203.
J Immunol. 1992 Oct 1;149(7):2241-8.
The organs in which B cells bearing membrane-bound IgE (sIgE+) and benzylpenicilloyl (BPO)-specific IgE antibody-forming cells (AFC) first appeared were determined in BALB/c mice given BPO-keyhole limpet hemocyanin (10 micrograms) in aluminum hydroxide by various routes (i.p, gavage, s.c., i.v., or i.m.). In mice immunized by the i.p. route, the numbers and location of sIgE+ B cells and asialo GM1 ganglioside (AsGm1+) cells, the location of IgE/CD23 immune complexes, and the numbers of BPO-specific IgE AFC in lymphoid organs were determined. With all routes of immunization, no sIgE+ B cells or BPO-specific IgE AFC were ever detected in any organ before day 8. On day 8, with the s.c., i.v., or i.m. routes, sIgE+ B cells and IgE AFC appeared exclusively in Peyer's patches (PP); with the i.p. or gavage routes, sIgE+ B cells simultaneously appeared in both PP and mesenteric lymph nodes, whereas IgE AFC appeared only in PP. In mice immunized by the i.p. route, IgE/CD23 immune complexes and strikingly increased numbers of AsGm1+ cells transiently appeared only in PP after the appearance and preceding the "disappearance" of the sIgE+ B cells and IgE AFC. The data suggest that specific IgE responses originate in gut-associated lymphoid tissue and appear later in spleen. The data also associate the appearance of IgE/CD23 immune complexes and AsGm1+ cells with the "disappearance" of sIgE+ B cells and IgE AFC from PP.
通过不同途径(腹腔注射、灌胃、皮下注射、静脉注射或肌肉注射)给BALB/c小鼠注射氢氧化铝佐剂中的苄青霉素酰基(BPO)-钥孔戚血蓝蛋白(10微克),确定带有膜结合型IgE(sIgE+)和BPO特异性IgE抗体形成细胞(AFC)的B细胞首先出现的器官。对于通过腹腔注射途径免疫的小鼠,确定了淋巴器官中sIgE+ B细胞和去唾液酸GM1神经节苷脂(AsGm1+)细胞的数量和位置、IgE/CD23免疫复合物的位置以及BPO特异性IgE AFC的数量。在所有免疫途径中,在第8天之前,任何器官中均未检测到sIgE+ B细胞或BPO特异性IgE AFC。在第8天,通过皮下注射、静脉注射或肌肉注射途径,sIgE+ B细胞和IgE AFC仅出现在派尔集合淋巴结(PP)中;通过腹腔注射或灌胃途径,sIgE+ B细胞同时出现在PP和肠系膜淋巴结中,而IgE AFC仅出现在PP中。对于通过腹腔注射途径免疫的小鼠,在sIgE+ B细胞和IgE AFC出现后且在其“消失”之前,IgE/CD23免疫复合物和显著增加的AsGm1+细胞数量仅短暂出现在PP中。数据表明,特异性IgE反应起源于肠道相关淋巴组织,随后出现在脾脏中。数据还将IgE/CD23免疫复合物和AsGm1+细胞的出现与sIgE+ B细胞和IgE AFC从PP中的“消失”相关联。